Cargando…
In silico studies on marine actinomycetes as potential inhibitors for Glioblastoma multiforme
Glioblastoma multiforme (GBM) is considered to be the most common and often deadly disorder which affects the brain. It is caused by the over expression of proteins such as ephrin type-A receptor 2 (EphA2), epidermal growth factor receptor (EGFR) and EGFRvIII. These 3 proteins are considered to be t...
Autores principales: | Kirubakaran, Palani, Kothapalli, Roopa, Singh, Kh Dhanachandra, Nagamani, Selvaraman, Arjunan, Subramanian, Muthusamy, Karthikeyan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Biomedical Informatics
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3089882/ https://www.ncbi.nlm.nih.gov/pubmed/21584184 |
Ejemplares similares
-
Combined sequence and sequence-structure based methods for analyzing FGF23, CYP24A1 and VDR genes
por: Nagamani, Selvaraman, et al.
Publicado: (2016) -
E-Pharmacophore mapping and docking studies on Vitamin D receptor (VDR)
por: Nagamani, Selvaraman, et al.
Publicado: (2012) -
A theoretical insight to understand the molecular mechanism of dual target ligand CTA-018 in the chronic kidney disease pathogenesis
por: Nagamani, Selvaraman, et al.
Publicado: (2018) -
Proteo-transcriptomics meta-analysis identifies SUMO2 as a promising target in glioblastoma multiforme therapeutics
por: Krishna, Aswani P., et al.
Publicado: (2021) -
Phytanoyl-CoA 2-Hydroxylase-Interacting Protein-Like Gene Is a Therapeutic Target Gene for Glioblastoma Multiforme
por: Fu, HuangDe, et al.
Publicado: (2019)